These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21076495)

  • 1. Effect of asymmetry of concentration-response curves on the results obtained by the receptorial responsiveness method (RRM): an in silico study.
    Grenczer M; Zsuga J; Majoros L; Pinter A; Kemeny-Beke A; Juhasz B; Tosaki A; Gesztelyi R
    Can J Physiol Pharmacol; 2010 Nov; 88(11):1074-83. PubMed ID: 21076495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of affinity, efficacy, and slope factor on the estimates obtained by the receptorial responsiveness method (RRM): a computer simulation study.
    Grenczer M; Pinter A; Zsuga J; Kemeny-Beke A; Juhasz B; Szodoray P; Tosaki A; Gesztelyi R
    Can J Physiol Pharmacol; 2010 Nov; 88(11):1061-73. PubMed ID: 21076494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy and Precision of the Receptorial Responsiveness Method (RRM) in the Quantification of A
    Szabo AM; Viczjan G; Erdei T; Simon I; Kiss R; Szentmiklosi AJ; Juhasz B; Papp C; Zsuga J; Pinter A; Szilvassy Z; Gesztelyi R
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of allosterism in functional assays.
    Ehlert FJ
    J Pharmacol Exp Ther; 2005 Nov; 315(2):740-54. PubMed ID: 16046613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for positive allosteric modulators: assessment of modulator concentration-response curves as a screening paradigm.
    Langmead CJ
    J Biomol Screen; 2007 Aug; 12(5):668-76. PubMed ID: 17478477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of the way of regression on the results obtained by the receptorial responsiveness method (RRM), a procedure to estimate a change in the concentration of a pharmacological agonist near the receptor.
    Ovari I; Viczjan G; Erdei T; Takacs B; Tarjanyi V; Zsuga J; Szucs M; Szilvassy Z; Juhasz B; Gesztelyi R
    Front Pharmacol; 2024; 15():1375955. PubMed ID: 38756379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mechanistic, predictive model of dose-response curves for cell cycle phase-specific and -nonspecific drugs.
    Gardner SN
    Cancer Res; 2000 Mar; 60(5):1417-25. PubMed ID: 10728708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of drug-receptor interactions in vivo: a new approach in pharmacokinetic-pharmacodynamic modelling.
    Van der Graaf PH; Danhof M
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):442-6. PubMed ID: 9352393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of models for analysis of radioligand binding data.
    Abramson SN; McGonigle P; Molinoff PB
    Mol Pharmacol; 1987 Jan; 31(1):103-11. PubMed ID: 3027522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutual-effect amplification of contractile responses elicited by simultaneous activation of alpha-1 adrenergic and 5-hydroxytryptamine2 receptors in isolated rat aorta.
    Christ GJ; Jean-Jacques M
    J Pharmacol Exp Ther; 1991 Feb; 256(2):553-61. PubMed ID: 1847200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonist inhibition curves and the measurement of dissociation constants.
    Barlow RB; Bond SM; Bream E; Macfarlane L; McQueen DS
    Br J Pharmacol; 1997 Jan; 120(1):13-8. PubMed ID: 9117087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Z-analysis: a new approach to analyze stimulation curves with intrinsic basal stimulation.
    Hedlund PB; von Euler G
    Biochem Pharmacol; 2005 Jul; 70(1):170-5. PubMed ID: 15899474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-based pharmacokinetic-pharmacodynamic modeling of the effects of N6-cyclopentyladenosine analogs on heart rate in rat: estimation of in vivo operational affinity and efficacy at adenosine A1 receptors.
    Van Der Graaf PH; Van Schaick EA; Math-ot RA; Ijzerman AP; Danhof M
    J Pharmacol Exp Ther; 1997 Nov; 283(2):809-16. PubMed ID: 9353402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining the error of dose estimates and minimum and maximum acceptable concentrations from assays with nonlinear dose-response curves.
    Gottschalk PG; Dunn JR
    Comput Methods Programs Biomed; 2005 Dec; 80(3):204-15. PubMed ID: 16256244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new method for estimation of agonist dissociation constants (KA): directly fitting the postinactivation concentration-response curve to a nested hyperbolic equation.
    James MK; Morgan PH; Leighton HJ
    J Pharmacol Exp Ther; 1989 Apr; 249(1):61-9. PubMed ID: 2540322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressions.
    Kenakin TP
    Mol Pharmacol; 1992 Apr; 41(4):699-707. PubMed ID: 1569922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and analysis of in vitro antitumor pharmacodynamic studies.
    Kalns JE; Millenbaugh NJ; Wientjes MG; Au JL
    Cancer Res; 1995 Nov; 55(22):5315-22. PubMed ID: 7585594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mathematical approach to predicting biological values from ruminal pH measurements.
    AlZahal O; Kebreab E; France J; McBride BW
    J Dairy Sci; 2007 Aug; 90(8):3777-85. PubMed ID: 17638989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the parameters of the operational model of pharmacological agonism.
    Frigyesi A; Hössjer O
    Stat Med; 2006 Sep; 25(17):2932-45. PubMed ID: 16287202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling of the time-dependency of in vitro drug cytotoxicity and resistance.
    Levasseur LM; Slocum HK; Rustum YM; Greco WR
    Cancer Res; 1998 Dec; 58(24):5749-61. PubMed ID: 9865733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.